Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Uroxatral (alfuzosin hydrochloride) extended release tablets, 10 mg Sanofi-Synthelabo NDA 21-287/S1 7/15/03 7/28/03 Uroxatral (alfuzosin hydrochloride) extended release tablets, 10 mg Sanofi-Synthelabo NDA 21-287 | Uroxatral (alfuzosin HCl) extended release tablets, Sanofi-Aventis, Labeling Revision | Uroxatral (alfuzosin HCl) Extended-Release Tablets, Sanofi-Aventis, Labeling Revision | Uroxatral (alfuzosin hydrochloride) Extended Release Tablets, Sanofi-Aventis US, LLC, Labeling Revision | Uroxatral (alfuzosin hydrochloride) Extended-Release Tablets, Sanofi-Aventis US, LLC, Labeling Revision | Alfuzosin Hydrochloride Extended-Release Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Aurobindo Pharma Ltd., Tentative Approval | Alfuzosin Hydrochloride Extended-Release Tablets, TEVA Pharmaceuticals USA, Tentative Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Sun Pharma Global Inc., Tentative Approval | Uroxatral (alfuzosin hydrochloride) Extended Release Tablets, Sanofi-Aventis U.S. LLC, Labeling Revision | Alfuzosin Hydrochloride Extended-Release Tablets, Invagen Pharmaceuticals Inc., Tentative Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Apotex Inc., Tentative Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Wockhardt, Ltd., Tentative Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Torrent Pharma Inc., Tentative Approval | Uroxatral (alfuzosin hydrochloride) Extended-Release Tablets, sanofi-aventis U.S., LLC, Labeling Revision | Alfuzosin Hydrochloride Extended-release Tablets, Torrent Pharmaceuticals, Tentative Approval | Uroxatral (alfuzosin hydrochloride) Extended-Release Tablets, sanofi-aventis U.S., LLC, Efficacy Supplement with Clinical Data to Support | Alfuzosin Hydrochloride Extended-Release Tablets, Apotex Inc., Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Mylan Pharmaceuticals, Inc., Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Sun Pharma Global FZE, Approval | Alfuzosin Hydrochloride Extended-Release Tablets, TEVA Pharmaceuticals USA, Approval | Alfuzosin Hydrochloride Extended-Release Tablets, Torrent Pharmaceuticals Ltd., Approval | Alfuzosin Hydrochloride, alfuzosin hydrochloride, Tablet, Extended Release; Oral, Invagen Pharms, Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com